NCT04568382

Brief Summary

The objective of this proposal is to pilot test two types of pre-visit planning, where clinical staff reviews charts and talks to patients before their doctors appointments, to reduce the burden of diabetes care on the patient without increasing the visit workload during busy primary care clinics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 29, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

October 12, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

November 15, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

September 11, 2020

Last Update Submit

November 14, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pilot feasibility

    patients reached by phone for PVP call after assigned to call; # patients recruited successfully who were eligible; # questions completed on the surveys; # calls made to each patient and to patients total per # patients reached and # patients enrolled; # patients who completed all surveys; qualitative interviews will discuss challenges, barriers, and other feasability concerns to scaling this pilot trial to a definitive multi-center trial

    at completion of study, 4 months after last study visit

  • Pilot acceptability)

    a short survey measuring PCPs perception of the visit's difficulty, hassle and effort; qualittive interviews with patients, providers and those conducting the intervention PVP calls

    after each clinic visit, within 2 weeks; at end of study

Secondary Outcomes (14)

  • Treatment Burden of Diabetes Care Questionnaire (TBQ)

    change from baseline to 4 months post visit

  • Patient Experience with Treatment and Self-Management (PETS) Questionnaire Medical Expenses Subsection

    change from baseline to 4 months post visit

  • Healthcare Climate Questionnaire (HCQ)

    change from baseline to 4 months post visit

  • Patient Self-Activation Measure (PAM-13) short form

    change from baseline to 4 months post visit

  • Perceived Diabetes Self-Management Scale

    change from baseline to 4 months post visit

  • +9 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Enhanced PVP

Other: CI-PVP (context-informed pre-visit planning)

Standard

ACTIVE COMPARATOR

Standard PVP

Other: Standard PVP (pre-visit planning)

Interventions

may experience a single additional phone call from clinic staff in addition to the standard clinic staff chart review, email and/or phone call prior to diabetes office visit

Intervention

standard clinic staff chart review, email and/or phone call prior to diabetes office visit

Standard

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients:
  • patient at the UCD ACC family medicine residency clinic
  • age 18+,
  • has diabetes per Diabetes Registry (HealthyPlanet2020)
  • PLUS at least one other chronic condition
  • attends a primary care office visit (in-person or telehealth) during the study initial data collection period with a physician who is participating in the study
  • speaks and writes English well enough to complete a written or oral survey
  • consents to participate
  • PCPs:
  • sees patients as a primary care physician at the study clinic site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Davis

Sacramento, California, 95817, United States

Location

Related Publications (1)

  • Magnan E, Gosdin M, Tancredi D, Jerant A. Pilot randomized controlled trial Protocol: Life context-informed pre-visit planning to improve care plans for primary care patients with multiple chronic conditions including diabetes. J Multimorb Comorb. 2021 Dec 1;11:26335565211062387. doi: 10.1177/26335565211062387. eCollection 2021 Jan-Dec.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Multiple Chronic Conditions

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Elizabeth Magnan, MD

    UCDavis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 11, 2020

First Posted

September 29, 2020

Study Start

October 12, 2020

Primary Completion

November 30, 2021

Study Completion

June 30, 2023

Last Updated

November 15, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Plan to share anonymized or de-identified data per IRB approval to researchers at my institution.

Locations